A Phase 2b Study of CITI-002 in Patients with Grade 2 and 3 Haemorrhoids

Trial Profile

A Phase 2b Study of CITI-002 in Patients with Grade 2 and 3 Haemorrhoids

Planning
Phase of Trial: Phase II

Latest Information Update: 13 Mar 2018

At a glance

  • Drugs Lidocaine/hydrocortisone (Primary)
  • Indications Haemorrhoids
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Mar 2018 New trial record
    • 06 Mar 2018 According to a Citius Pharmaceuticals media release, following a Type C meeting with the FDA which included discussion of results of the phase 2a study, the company also requested the Agencys feedback on the phase 2b study design, including target patient population, inclusion/exclusion criteria, and efficacy endpoints.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top